[Federal Register Volume 63, Number 29 (Thursday, February 12, 1998)] [Notices] [Page 7181] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 98-3611] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Application Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on December 8, 1997, Johnson & Johnson Pharmaceutical Partners, HC-02 State Road 933, KMO.1 Mamey Ward HC-02 Box 19250, Gurabo, Puerto Rico 00778-9629, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of sufentanil (9740), a basic class of controlled substance listed in Schedule II. The firm plans to manufacture sufentanil for bulk distribution to its customers. Any other such applicant and any person who is presently registered with DEA to manufacture such substance may file comments or objections to the issuance of the proposed registration. Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than April 13, 1998. Dated: January 21, 1998. John H. King, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 98-3611 Filed 2-11-98; 8:45 am] BILLING CODE 4410-09-M